Shares of Scienture Holdings, Inc. (SCNX) are moving up about 31 percent on Wednesday morning trading after the company formalized multiple commercial Group Purchasing Organization agreements for REZENOPYTM (naloxone HCl) Nasal Spray 10 mg.
The company's shares are currently trading at $0.51 on the Nasdaq, up 31.40 percent. The stock opened at $0.61 and has climbed as high as $0.64 so far in today's session. Over the past year, it has traded in a range of $0.37 to $3.17.
The agreements are expected to expand the company's institutional reach, providing access to more than 5000 healthcare facilities representing potential penetration into approximately 60% of the U.S. institutional market.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.